Health care providers acceptance of default prescribing of TB preventive treatment for people living with HIV in Malawi: a qualitative study

被引：0
作者：
L. M. De Groot
K. Shearer
C. Sambani
E. Kaonga
R. Nyirenda
K. Mbendera
J. E. Golub
C. J. Hoffmann
C. Mulder
机构：
[1] TB Elimination and Health System Innovations – KNCV Tuberculosis Foundation,Center for Tuberculosis Research
[2] John Hopkins University,Division of Infectious Diseases, School of Medicine
[3] Johns Hopkins University,Department of Research
[4] Ministry of Health,Department of HIV and AIDS
[5] KNCV Tuberculosis Foundation,National Tuberculosis and Leprosy Elimination Program
[6] Ministry of Health,Department of Epidemiology
[7] Ministry of Health,Department of Health, Behavior and Society
[8] Johns Hopkins Bloomberg School of Public Health,Amsterdam Institute for Global Health and Development
[9] Johns Hopkins Bloomberg School of Public Health,undefined
[10] Amsterdam University Medical Centres,undefined
来源：
BMC Health Services Research | / 24卷
关键词：
Tuberculosis; Preventive treatment; Choice architecture; People living with HIV; Acceptability; Health care providers;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 101 条
  • [1] Pathmanathan I(2018)TB preventive therapy for people living with HIV: key considerations for scale-up in resource-limited settings Int J Tuberc Lung Dis 22 596-605
  • [2] Ahmedov S(2021)HIV-associated Tuberculosis Int J STD AIDS 32 780-90
  • [3] Pevzner E(2015)Isoniazid Prophylactic Therapy for the Prevention of Tuberculosis in HIV infected adults: a systematic review and Meta-analysis of Randomized trials PLoS ONE 10 e0142290-305
  • [4] Anyalechi G(2021)Economic and modeling evidence for Tuberculosis preventive therapy among people living with HIV: a systematic review and meta-analysis PLoS Med 18 e1003712-7
  • [5] Modi S(2015)Use of isoniazid preventive therapy for Tuberculosis prophylaxis among people living with HIV/AIDS: a review of the literature J Acquir Immune Defic Syndr 68 297-8
  • [6] Kirking H(2016)Barriers in the implementation of isoniazid preventive therapy for people living with HIV in Northern Ethiopia: a mixed quantitative and qualitative study BMC Public Health 16 840-504
  • [7] Hamada Y(2011)Predictors of adherence to isoniazid preventive therapy among HIV positive adults in Addis Ababa, Ethiopia BMC Public Health 11 916-9
  • [8] Getahun H(2018)Factors affecting the acceptability of isoniazid preventive therapy among healthcare providers in selected HIV clinics in Nairobi County, Kenya: a qualitative study BMJ Open 8 e024286-16
  • [9] Tadesse BT(2019)Provider barriers to the uptake of isoniazid preventive therapy among people living with HIV in Ethiopia Int J Tuberc Lung Dis 23 371-620
  • [10] Ford N(2010)Barriers to implementation of isoniazid preventive therapy in HIV clinics: a qualitative study Aids 24 45-22
12345678910